ArticleFrontiers in oncology2023

Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myeloma.

Lukas John et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.